Enjoy complimentary customisation on priority with our Enterprise License!
The clinical trial support services market size is forecast to increase by USD 7.95 billion at a CAGR of 7.08% between 2023 and 2028. The market is experiencing significant growth, driven by the expansion of the biopharmaceutical industry and the increasing demand for Contract Research Organizations (CROs). The market is particularly active in disease areas such as Alzheimer's disease and other dementias, arthritis, cancer, and diabetes. The high cost of clinical trials, driven by the complexity of research and regulatory requirements, is a major challenge for market participants. Clinton IT Services and other providers are addressing this challenge by leveraging advanced technologies, such as artificial intelligence and machine learning, to streamline clinical trial processes and reduce costs. The growing adoption of these technologies is expected to accelerate market growth in the coming years.
The market plays a pivotal role in the biopharmaceutical and medical device industries by providing essential services for conducting clinical trials. These services include assay design, patient recruiting, site management, and clinical solutions for various diseases such as Alzheimer's disease, dementias, arthritis, cancer, diabetes, heart disease, obesity, osteoporosis, tobacco-related disorders, and more. Chronic diseases like diabetes, insulin resistance, and hyperlipidemia, as well as infectious diseases like HIV, hepatitis, and tropical diseases such as dengue (DENV), require extensive clinical research. Oracle Clinical and other clinical trial support service providers support these efforts by streamlining the clinical trial process, ensuring data accuracy, and maintaining regulatory compliance.
Further, biopharmaceutical and medical device companies rely on these services to bring new treatments and medical devices to market, ultimately improving patient care and quality of life. The market for clinical trial support services is expected to grow significantly due to the increasing prevalence of chronic and infectious diseases and the rising demand for new treatments and medical devices.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD Billion" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
The phase 2 segment is estimated to witness significant growth during the forecast period. In the market, Phase 2 signifies the intermediate stage of clinical research where a treatment's efficacy and safety are assessed in a larger patient population. This phase is pivotal in establishing the optimal dosage and safety profile before progressing to Phase 3. Key services offered during this phase include patient recruitment, site selection and management, clinical monitoring, data management, and regulatory compliance. Meticulous data collection and analysis are prioritized to ensure reliable results.
Additionally, outsourcing these services to expert organizations guarantees quality, expediency, and cost savings. The wave in clinical trial complexity and the requirement for authentic, real-world evidence to support advancement fuel the demand for Phase 2 clinical trial support services. Heart disease, obesity, osteoporosis, tobacco-related disorders, irritable bowel syndrome, and osteoarthritis are some of the major disease areas where these services are in high demand.
Get a glance at the market share of various segments Request Free Sample
The phase 2 segment accounted for USD 5.86 billion in 2018 and showed a gradual increase during the forecast period.
Asia is estimated to contribute 31% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market share of various regions Request Free Sample
The European market caters to a significant portion of the global clinical trials industry, with key contributors being Germany, France, the UK, Switzerland, and Italy. Pharmaceutical, biologics, and medical technology companies in these countries drive the market's growth due to the high demand for clinical trials. Europe's medical technology sector, consisting of medical devices and in-vitro diagnostic products, primarily manufactured in countries like Germany, France, Italy, and the UK. This industry is fueled by the rising healthcare applications demand, including diagnostics and imaging, orthopedics, drug delivery, wound management, general and plastic surgery, osteoporosis treatment, tobacco-related disorders management, irritable bowel syndrome treatment, and osteoarthritis care. Heart disease treatments also represent a substantial market opportunity.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The growth of biopharmaceutical industry is the key driver of the market. The biopharmaceutical sector encompasses manufacturers and suppliers of biologics and pharmaceutical products. This industry sector is experiencing significant growth and financial success, driven by biologics innovators, investors, and suppliers. The pharmaceutical industry's focus on discovering new drugs and biosimilars is shifting towards the biopharmaceutical sector, with new global participants entering the market. Biopharmaceuticals have made a significant impact on previously untreatable conditions, particularly in areas such as cancer, neurology (including Alzheimer's disease and dementias), diabetes, and immunology. In the last decade, biopharmaceuticals have contributed to a reduction in cancer and HIV/AIDS deaths, leading to increased adoption and demand in the global market. Approximately 70% of potential medicines in development represent novel approaches to treating diseases in these areas.
Growing demand for CROs is the upcoming trend in the market. Pharmaceutical companies frequently outsource their clinical trial processes to Contract Research Organizations (CROs) to concentrate on research and development and minimize operational expenses. The rise in the number of CROs is anticipated to persist due to the growing trend of outsourcing. In developed countries, high research and development costs have deterred several organizations from establishing their facilities due to substantial capital requirements. By engaging subcontract laboratories for research and testing, companies can drive innovation and optimize costs. Conditions such as Alzheimer's disease, Dementias, Arthritis, Cancer, and Diabetes are major areas of focus for clinical trials in these CROs. These trials aim to discover new treatments and therapies for these diseases, ultimately improving patient care and outcomes.
The high cost of clinical trials is a key challenge affecting the market growth. The market has witnessed significant growth due to the increasing complexity and costs associated with drug clinical trials. Patient recruitment and retention remain major challenges, as trials for chronic conditions like Alzheimer's disease, arthritis, cancer, and diabetes require large and diverse patient populations. Additionally, stringent regulations necessitate extensive safety testing and data collection, leading to prolonged clinical trials. Clinion IT Services and other providers offer solutions to manage these challenges, ensuring efficient patient enrollment, data management, and regulatory compliance. These services enable sponsors to bring life-changing therapies to market while maintaining the highest standards of safety and efficacy.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
AH UK Holdco 1 Ltd. - The company offers clinical trial support services such as packaging services, analytical solutions and contract manufacturing.
The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Clinical trial support services play a crucial role in the biopharmaceutical and medical device industries, facilitating the development of new treatments and therapies for various chronic and infectious diseases. These services encompass patient recruitment management, data management, administrative staffing, and clinical solutions for conditions such as Alzheimer's disease, dementia, arthritis, cancer, diabetes, heart disease, obesity, osteoporosis, tobacco-related disorders, irritable bowel syndrome, osteoarthritis, Dengue virus (DENV), and Monkeypox virus. Patient recruitment is a significant challenge in clinical trials, and effective management is essential to ensure the timely completion of studies. Data management involves the collection, validation, and analysis of clinical trial data using both open-source and proprietary software.
Further, administrative staffing includes the recruitment and training of personnel for clinical test sites. Clinical trials for chronic diseases like diabetes, insulin resistance, and hyperlipidemia require complex dosing schedules and sample collection management. Infectious diseases, such as DENV and Monkeypox virus, present unique challenges due to their potential for rapid spread and the need for stringent regulatory submission studies. Biopharmaceutical and medical device companies rely on clinical trial support services to design assays, manage sites, maintain audit trails, and ensure regulatory compliance throughout the trial process. Oracle Clinical and other clinical solutions provide essential tools for managing the complexity of clinical trials, enabling the development of new treatments and therapies for a range of diseases.
Market Scope |
|
Report Coverage |
Details |
Page number |
159 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.08% |
Market Growth 2024-2028 |
USD 7.95 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
6.49 |
Regional analysis |
Europe, North America, Asia, and Rest of World (ROW) |
Performing market contribution |
Asia at 31% |
Key countries |
US, Japan, China, Germany, and France |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
AH UK Holdco 1 Ltd., Almac Group Ltd., Brighter Health Network LLC, Catalent Inc., Charles River Laboratories International Inc., Clinipace Inc., Eli Lilly and Co., Eurofins Scientific SE, ICON plc, IQVIA Holdings Inc., Laboratory Corp. of America Holdings, MARKEN Ltd., Parexel International Corp., Pfizer Inc., PharmNet.Bund, Quotient Sciences Ltd., Seveillar Clinical Supplies Services Pvt. Ltd., Syneos Health Inc., Thermo Fisher Scientific Inc., and WuXi AppTec Co. Ltd. |
Market dynamics |
Parent market analysis, market growth inducers and obstacles, market forecast, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, market condition analysis for the forecast period |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Age Group
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.